Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CALCIPOTRIOL BETAMETHASONE DIPROPIONATE
Profind Wholesale Ltd.
50 + 0.5
Ointment
2010-06-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dovobet 50 micrograms/0.5mg/g ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of ointment contains 50 micrograms of calcipotriol (as monohydrate) and 0.5mg betamethasone (as dipropionate). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Ointment. _Product imported from the UK:_ Off-white to yellow ointment. _Product imported from Italy:_ Off-white to yellow ointment. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Dovobet ointment should be applied to the affected area once daily. The recommended treatment period is 4 weeks. There is experience with repeated courses of Dovobet up to 52 weeks. If it is necessary to continue or restart treatment after 4 weeks, treatment should be continued after medical review and under regular medical supervision. When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g. The body surface area treated with calcipotriol containing medicinal products should not exceed 30 % (see section 4.4). Special populations _Renal and hepatic impairment_ The safety and efficacy of Dovobet ointment in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated. Paediatric population The safety and efficacy of Dovobet ointment in children below 18 years have not been established. No data are available. METHOD OF ADMINISTRATION Dovobet ointment should be applied to the affected area. In order to achieve optimal effect, it is not recommended to take a shower or bath immediately after application of Dovobet ointment. IRISH MEDICINES BOARD ____________________ Read the complete document